RenovoRx (RNXT) Enterprise Value (2021 - 2026)

RenovoRx has disclosed Enterprise Value across 6 years of filings, most recently posting $34.7 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 3.71% year-over-year to $34.7 million; the TTM figure through Jun 2026 stood at $34.7 million (down 3.71% YoY), while the FY2025 annual figure was $23.7 million, changed 0.5% from the prior year.
• Enterprise Value came in at $34.7 million for Q2 2026 at RenovoRx, up from $33.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $36.5 million in Q3 2025 to a low of $7.2 million in Q2 2022.
• Average Enterprise Value over 5 years is $21.4 million, with a median of $19.9 million recorded in 2024.
• Year-over-year, Enterprise Value slumped 37.04% in 2022 and jumped 152.75% in 2023.
• Over 5 years, Enterprise Value stood at $14.9 million in 2022, then surged by 56.06% to $23.3 million in 2023, then advanced by 2.3% to $23.9 million in 2024, then dropped by 0.5% to $23.7 million in 2025, then soared by 46.3% to $34.7 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $34.7 million in Q2 2026, $33.1 million in Q1 2026, and $23.7 million in Q4 2025.